| Primary Device ID | 00816270020095 |
| NIH Device Record Key | 0c162c60-2ff1-4a56-ad37-1f83a3f3e165 |
| Commercial Distribution Status | In Commercial Distribution |
| Brand Name | NextSeq550Dx Reagent Kit v2(300 cyc) IVD |
| Version Model Number | 20019554 |
| Catalog Number | 20019554 |
| Company DUNS | 033305264 |
| Company Name | ILLUMINA, INC. |
| Device Count | 1 |
| DM Exempt | false |
| Pre-market Exempt | true |
| MRI Safety Status | Labeling does not contain MRI Safety Information |
| Human Cell/Tissue Product | false |
| Device Kit | true |
| Device Combination Product | false |
| Single Use | true |
| Lot Batch | true |
| Serial Number | false |
| Manufacturing Date | false |
| Expiration Date | true |
| Donation Id Number | false |
| Contains Natural Rubber Latex | false |
| Labeled No Natural Rubber Latex | false |
| RX Perscription | true |
| OTC Over-The-Counter | false |
| Storage Environment Temperature | Between -25 Degrees Celsius and -15 Degrees Celsius |
| Storage Environment Temperature | Between -25 Degrees Celsius and -15 Degrees Celsius |
| Storage Environment Temperature | Between -25 Degrees Celsius and -15 Degrees Celsius |
| Device Issuing Agency | Device ID |
|---|---|
| GS1 | 00816270020095 [Primary] |
| PFT | Reagents For Molecular Diagnostic Test Systems |
| Steralize Prior To Use | false |
| Device Is Sterile | false |
| Public Version Status | Update |
| Device Record Status | Published |
| Public Version Number | 3 |
| Public Version Date | 2019-03-01 |
| Device Publish Date | 2018-02-09 |
| 00816270020217 - TruSight™ Oncology Comprehensive | 2024-12-17 The TruSight Oncology Comprehensive assay is an enrichment-based targeted next generation sequencing (NGS) in-vitro diagnostic t |
| 00816270020644 - TruSight™ Oncology RNA Control | 2024-12-17 The TruSight Oncology DNA Control and TruSight Oncology RNA Control are control materials sold separately for use as a quality |
| 00816270020651 - TruSight™ Oncology DNA Control IVD | 2024-12-17 The TruSight Oncology DNA Control and TruSight Oncology RNA Control are control materials sold separately for use as a quality |
| 00816270020262 - Local Run Manager CF Clinical Sequencing Analysis Module | 2023-07-13 The Local Run Manager CF Clinical Sequencing analysis module is for use with Illumina MiSeqDx Cystic Fibrosis Clinical Sequencin |
| 00816270020286 - Local Run Manager CF 139 Variant Analysis Module | 2023-07-13 The Local Run Manager CF 139 Variant analysis module is for use with Illumina MiSeqDx Cystic Fibrosis 139-Variant Assay. The ass |
| 00816270020378 - Local Run Manager CF 139-Variant 2.0 Micro Analysis Module | 2023-07-13 The Local Run Manager CF 139-Variant 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis 139-Variant Assay when p |
| 00816270020385 - Local Run Manager CF Clinical Seq 2.0 Micro Analysis Module | 2023-07-13 The Local Run Manager CF Clinical Seq 2.0 Micro analysis module is for use with TruSight Cystic Fibrosis Clinical Sequencing Ass |
| 00816270020392 - Local Run Manager DNA GenerateFASTQ Dx Module for MiSeq™Dx | 2022-11-15 The Local Run Manager (LRM) DNA GenerateFASTQ Dx Module for MiSeq™Dx is used for sequencing run setup, run monitoring, and pri |